Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing.

Mainly because of their relative simplicity, ease of manipulation and growth in vitro, and importance in medicine, bacteria were instrumental in the development of molecular biology.

Scope of the Report:
Molecular diagnostics are highly effective in diagnosing infectious diseases and performing preventive cancer screening thus helping healthcare professionals to prescribe accurate therapeutic interventions in the early stages of diseases. Increasing prevalence of hospital acquired infections and other communicable infections are anticipated to drive the sector expansion over the forecast period.
The classification of molecular microbiology includes quantitative PCR detection diagnostic kits, pathogenic microorganisms’ diagnostic kits and other. The proportion of pathogenic microorganisms’ diagnostic kits in 2016 is about 45.8%. PCR was the largest segment in terms of revenue generation, Moreover, the growing availability of diseases-specific; real time PCR kits are further estimated to boost the growth.
Molecular Microbiology is application for human and veterinary. The most of Molecular Microbiology is used for human, and the market share in 2016 is about 92.5%.
The worldwide market for Molecular Microbiology is expected to grow at a CAGR of roughly 10.2% over the next five years, will reach 8290 million US$ in 2024, from 4630 million US$ in 2019, according to a new study.
This report focuses on the Molecular Microbiology in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Quantitative PCR Detection Diagnostic Kits
Pathogenic Microorganisms Diagnostic Kits

Market Segment by Applications, can be divided into
Human
Veterinary

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Molecular Microbiology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Molecular Microbiology, with price, sales, revenue and global market share of Molecular Microbiology in 2017 and 2018.
Chapter 3, the Molecular Microbiology competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Molecular Microbiology breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Molecular Microbiology market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Molecular Microbiology sales channel, distributors, customers, research findings and conclusion, appendix and data source.